Percutaneous Coronary Intervention Clinical Trial
Official title:
Effect of Ice Bag Application to Femoral Region on Pain in Patients Undergoing Percutaneous Coronary Intervention
Background: Removal of femoral arterial catheter causes pain, and current interventions used
for reducing this pain are not sufficiently effective.
Aims: The aim of this study is to determine the pain reduction effectiveness of ice bag
applications to the femoral region in patients undergoing percutaneous coronary
intervention.
Design: A randomized controlled trial with repeated measures and two-group design.
Setting: This study was conducted at the Yilmaz-Mehmet Oztaskın Heart and Vascular Hospital
located in Kayseri, Turkey.
Participants: The study was completed with a total of 104 patients who met the inclusion
criteria: 52 each in the experimental group and the control group.
Methods: The data were collected by the researcher using Patient Identification Form,
Numerical Rating Scale (NRS), and Vital Signs Monitoring Form. An ice bag was applied to
patients in the experimental group for 20 minutes before removal of the catheter. The nurse
performing the application was also responsible for the catheter removal, immediately after
the ice bag was removed. Standard procedures of the clinic were applied to the control
group. According to the relevant standard procedures, the catheter was removed by the nurse
without making any other application to femoral region, and pressure was applied on catheter
site. The pain experienced by the patients was evaluated before, and during removal and
again while the nurse applied pressure on the catheter site after removal. The NRS scores
were identified as NRS1, NRS2 and NRS3 for the three assessment, respectively.
Although several arterial access routes may be employed during percutaneous coronary
intervention (PCI), the femoral arterial site has been the most commonly used (1). However,
during femoral artery interventions, many patients experience pain and discomfort during the
removal of catheters previously inserted into the femoral region (2,3). Previous literature
also provides evidence that both vasovagal responses and local vascular complications may
develop when the pain induced by catheter removal is not effectively controlled (3-5);
therefore, it is important to reduce the pain experienced by patients undergoing this
procedure (6).
Pain caused by the removal of a femoral catheter may be controlled by using pharmacological
methods such as treatment with morphine sulfate or lidocaine infiltration (2,3). However, it
is also been observed that such approaches may cause complications such as increased
bleeding, laceration of catheters, infection and temporary nerve injury (7-9). Pain may be
also be controlled using non-pharmacological methods, which are patient-specific and aim to
establish empathic communication with healthcare staff (10-13). Non-pharmacological methods
used for pain control provided positive effects such as reduced anxiety and psychological
support; notably, patients have expressed satisfaction with such non-pharmacological methods
(14).
Cold application is a non-pharmacological method of pain control (6). Being one of the
oldest and easiest forms of treatment, cold-application increases the threshold of pain and
reduces the conduction velocity of nerve fibres transmitting pain stimuli from the
peripheral to the central nervous system (15). Demir et al. (10) investigated the effect of
cold application upon pain caused by the removal of a chest tube and revealed that cold
application reduced pain intensity and delayed patient requests for a second analgesic. In a
further study by Ertug et al. (11), cold application was highly effective in reducing the
pain caused by chest tube removal. Cold application also confers other advantages, such as
ease of application, the lack of serious side effects and low cost (16).
Aim and Hypothesis of the Study This study aimed to determine the effect of cold application
to the femoral region upon pain levels of patients receiving PCI. Our hypothesis was that
cold application would reduce (1) the pain score associated with removal of a femoral
catheter after PCI, (2) the behavioural responses of discomfort associated with removal of a
femoral catheter after PCI and (3) the incidence of adverse reactions associated with
removal of a femoral catheter after PCI.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Not yet recruiting |
NCT05669222 -
The FAVOR V AMI Trial
|
N/A | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Recruiting |
NCT05240781 -
Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk
|
N/A | |
Recruiting |
NCT03378934 -
Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
|
Phase 4 | |
Not yet recruiting |
NCT06025071 -
Residual Inflammatory Risk-Guided colcHicine in Elderly Trial
|
Phase 4 | |
Withdrawn |
NCT04043091 -
Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction
|
N/A | |
Completed |
NCT02837744 -
Studying Hemostatic Effect of Axiostat® Dressing on Radial Access After Percutaneous Procedure
|
||
Completed |
NCT03085823 -
The All-comers Sirolimus-coated Balloon European Registry
|
||
Completed |
NCT02044146 -
A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk
|
Phase 2/Phase 3 | |
Completed |
NCT01135667 -
Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI
|
Phase 4 | |
Completed |
NCT01156571 -
A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)
|
Phase 3 | |
Unknown status |
NCT00751491 -
Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI)
|
Phase 3 | |
Completed |
NCT00725868 -
Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention
|
N/A | |
Completed |
NCT03708588 -
Chewed Versus Integral Pill of Ticagrelor
|
Phase 4 | |
Completed |
NCT04163393 -
R-One Efficiency For PCI Evolution With Robotic Assistance
|
N/A | |
Recruiting |
NCT05554588 -
Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI
|
N/A | |
Recruiting |
NCT06080919 -
Plaque Modification And Impact On Microcirculatory Territory After Drug-Coated Balloon Percutaneous Coronary Intervention (PLAMI).
|
N/A | |
Recruiting |
NCT05353140 -
LAAO Versus NOAC in Patients With AF and PCI
|
N/A | |
Recruiting |
NCT06075433 -
Evaluating Efficacy and Safety of 1-year of DAPT After Genoss DES Sirolimus-eluting Stent Implantation in Patients
|